Machine learning predicts advanced-stage progression in patients with hepatocellular carcinoma, indicating potential benefits of systemic therapy post-TACE.
The CatBoost machine learning model accurately predicted advanced-stage progression of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization (TACE) and identified patients who benefited from post-TACE systemic therapy.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: